Ironshore Pharmaceuticals & Development, Inc.: Jornay PM Modified Release

Although Ritalin (the reference listed drug) labeling does not include data describing the rate of adverse reactions, a number of other approved methylphenidate product labels do.

To obtain marketing authorization for this patient population, you would need to conduct an additional study to find a lower dose that is safe and effective.